KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) EBITDA Margin (2016 - 2025)

Petmed Express' EBITDA Margin history spans 16 years, with the latest figure at 25.75% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 2488.0% year-over-year to 25.75%; the TTM value through Dec 2025 reached 31.56%, down 3180.0%, while the annual FY2025 figure was 1.57%, 269.0% up from the prior year.
  • EBITDA Margin reached 25.75% in Q4 2025 per PETS's latest filing, down from 18.89% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 13.09% in Q3 2021 to a low of 66.69% in Q2 2025.
  • Average EBITDA Margin over 5 years is 2.59%, with a median of 1.09% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: soared 722bps in 2024, then crashed -7331bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 9.67% in 2021, then tumbled by -97bps to 0.3% in 2022, then crashed by -782bps to 2.05% in 2023, then skyrocketed by 58bps to 0.87% in 2024, then crashed by -2873bps to 25.75% in 2025.
  • Per Business Quant, the three most recent readings for PETS's EBITDA Margin are 25.75% (Q4 2025), 18.89% (Q3 2025), and 66.69% (Q2 2025).